This Pharmaceutical Country Profile provides data on existing socio-economic
and health-related conditions, resources, regulatory structures, processes and
outcomes relating to the pharmaceutical sector of Saint Lucia. The aim of this
document is to compile all relevant, existing information on the pharmaceutical
sector and make it available to the public in a user-friendly format. In 2010, the
country profiles project was piloted in 13 countries
(http://www.who.int/medicines/areas/coordination/coordination_assessment/en/in
dex.html). During 2011, the World Health Organization has supported all WHO
Member States to develop similar comprehensive pharmaceutical country
profiles.
The information is categorized in 8 sections, namely: (1) Health and
Demographic data, (2) Health Services, (3) Policy issues, (4) Medicines Trade
and Production (5) Medicines Regulation, (6) Medicines Financing, (7)
Pharmaceutical procurement and distribution, and (8) Selection and rational use.
The indicators have been divided into two categories, namely "core" (most
important) and "supplementary" (useful if available). This narrative profile is
based on data derived from both the core and supplementary indicators. The
tables in the annexes also present all data collected for each of the indicators in
the original survey form. For each piece of information, the year and source of
the data are indicated; these have been used to build the references in the profile
and are also indicated in the tables. If key national documents are available online,
links have been provided to the source documents so that users can easily
access these documents